 | • レポートコード：QYR2104Z5095 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、風疹診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フロー細胞数測定、ラテックススライド凝集テスト、単クローン抗体、免疫測定法、血清学的試験、臨床評価、免疫測定法、血清学的試験、臨床評価）、用途別市場規模（病院、商業、診療所、保健所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・風疹診断検査の市場動向 ・企業の競争状況、市場シェア ・風疹診断検査の種類別市場規模（フロー細胞数測定、ラテックススライド凝集テスト、単クローン抗体、免疫測定法、血清学的試験、臨床評価 、免疫測定法、血清学的試験、臨床評価） ・風疹診断検査の用途別市場規模（病院、商業、診療所、保健所、その他） ・風疹診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・風疹診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・風疹診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・風疹診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・風疹診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Beckman Coulter、Bio Rad Laboratories、Biogate Laboratories、BioMerieux SA、Cigna、Diagnostic Laboratory of Oklahoma、GlaxoSmithKline、HealthLink BC、Mayo Clinic、Ortho Clinical Diagnostics、True Health） ・結論 |
Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects.
Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and MEA.
Market Analysis and Insights: Global Rubella Diagnostic Testing Market
The global Rubella Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rubella Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rubella Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rubella Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rubella Diagnostic Testing market.
Global Rubella Diagnostic Testing Scope and Market Size
Rubella Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rubella Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation
Segment by Application
Hospitals
Commercial
Physician Offices
Public Health Labs
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Biogate Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Flow Cytometry
1.2.3 Latex Slide Agglutination Test
1.2.4 Monoclonal Antibodies
1.2.5 Immunoassays
1.2.6 Serological Testing
1.2.7 Clinical Evaluation
1.3 Market by Application
1.3.1 Global Rubella Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Commercial
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rubella Diagnostic Testing Market Perspective (2016-2027)
2.2 Rubella Diagnostic Testing Growth Trends by Regions
2.2.1 Rubella Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rubella Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Rubella Diagnostic Testing Industry Dynamic
2.3.1 Rubella Diagnostic Testing Market Trends
2.3.2 Rubella Diagnostic Testing Market Drivers
2.3.3 Rubella Diagnostic Testing Market Challenges
2.3.4 Rubella Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Diagnostic Testing Players by Revenue
3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rubella Diagnostic Testing Revenue
3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2020
3.5 Rubella Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Rubella Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Rubella Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Diagnostic Testing Breakdown Data by Type
4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2022-2027)
5 Rubella Diagnostic Testing Breakdown Data by Application
5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Rubella Diagnostic Testing Market Size (2016-2027)
6.2 North America Rubella Diagnostic Testing Market Size by Type
6.2.1 North America Rubella Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America Rubella Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America Rubella Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America Rubella Diagnostic Testing Market Size by Application
6.3.1 North America Rubella Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America Rubella Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America Rubella Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America Rubella Diagnostic Testing Market Size by Country
6.4.1 North America Rubella Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America Rubella Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Rubella Diagnostic Testing Market Size (2016-2027)
7.2 Europe Rubella Diagnostic Testing Market Size by Type
7.2.1 Europe Rubella Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe Rubella Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe Rubella Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe Rubella Diagnostic Testing Market Size by Application
7.3.1 Europe Rubella Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe Rubella Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe Rubella Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe Rubella Diagnostic Testing Market Size by Country
7.4.1 Europe Rubella Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe Rubella Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Rubella Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Rubella Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rubella Diagnostic Testing Market Size (2016-2027)
9.2 Latin America Rubella Diagnostic Testing Market Size by Type
9.2.1 Latin America Rubella Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Rubella Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Rubella Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America Rubella Diagnostic Testing Market Size by Application
9.3.1 Latin America Rubella Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Rubella Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Rubella Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America Rubella Diagnostic Testing Market Size by Country
9.4.1 Latin America Rubella Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Rubella Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Rubella Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Bio Rad Laboratories
11.3.1 Bio Rad Laboratories Company Details
11.3.2 Bio Rad Laboratories Business Overview
11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.3.5 Bio Rad Laboratories Recent Development
11.4 Biogate Laboratories
11.4.1 Biogate Laboratories Company Details
11.4.2 Biogate Laboratories Business Overview
11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.4.5 Biogate Laboratories Recent Development
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Details
11.5.2 BioMerieux SA Business Overview
11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.5.5 BioMerieux SA Recent Development
11.6 Cigna
11.6.1 Cigna Company Details
11.6.2 Cigna Business Overview
11.6.3 Cigna Rubella Diagnostic Testing Introduction
11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.6.5 Cigna Recent Development
11.7 Diagnostic Laboratory of Oklahoma
11.7.1 Diagnostic Laboratory of Oklahoma Company Details
11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.7.5 Diagnostic Laboratory of Oklahoma Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 HealthLink BC
11.9.1 HealthLink BC Company Details
11.9.2 HealthLink BC Business Overview
11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.9.5 HealthLink BC Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.10.5 Mayo Clinic Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 True Health
11.12.1 True Health Company Details
11.12.2 True Health Business Overview
11.12.3 True Health Rubella Diagnostic Testing Introduction
11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2016-2021)
11.12.5 True Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Latex Slide Agglutination Test
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Immunoassays
Table 6. Key Players of Serological Testing
Table 7. Key Players of Clinical Evaluation
Table 8. Global Rubella Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Rubella Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Rubella Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Rubella Diagnostic Testing Market Share by Regions (2016-2021)
Table 12. Global Rubella Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Rubella Diagnostic Testing Market Share by Regions (2022-2027)
Table 14. Rubella Diagnostic Testing Market Trends
Table 15. Rubella Diagnostic Testing Market Drivers
Table 16. Rubella Diagnostic Testing Market Challenges
Table 17. Rubella Diagnostic Testing Market Restraints
Table 18. Global Rubella Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Rubella Diagnostic Testing Market Share by Players (2016-2021)
Table 20. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rubella Diagnostic Testing as of 2020)
Table 21. Ranking of Global Top Rubella Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Rubella Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rubella Diagnostic Testing Product Solution and Service
Table 25. Date of Enter into Rubella Diagnostic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rubella Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Rubella Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Rubella Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Rubella Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Rubella Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Rubella Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Rubella Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Rubella Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Rubella Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Rubella Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Rubella Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Rubella Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Rubella Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Rubella Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Rubella Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Rubella Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Rubella Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Rubella Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Rubella Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Rubella Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Rubella Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Rubella Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Rubella Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Rubella Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Rubella Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Rubella Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Rubella Diagnostic Testing Product
Table 68. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. Beckman Coulter Company Details
Table 71. Beckman Coulter Business Overview
Table 72. Beckman Coulter Rubella Diagnostic Testing Product
Table 73. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 74. Beckman Coulter Recent Development
Table 75. Bio Rad Laboratories Company Details
Table 76. Bio Rad Laboratories Business Overview
Table 77. Bio Rad Laboratories Rubella Diagnostic Testing Product
Table 78. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 79. Bio Rad Laboratories Recent Development
Table 80. Biogate Laboratories Company Details
Table 81. Biogate Laboratories Business Overview
Table 82. Biogate Laboratories Rubella Diagnostic Testing Product
Table 83. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 84. Biogate Laboratories Recent Development
Table 85. BioMerieux SA Company Details
Table 86. BioMerieux SA Business Overview
Table 87. BioMerieux SA Rubella Diagnostic Testing Product
Table 88. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 89. BioMerieux SA Recent Development
Table 90. Cigna Company Details
Table 91. Cigna Business Overview
Table 92. Cigna Rubella Diagnostic Testing Product
Table 93. Cigna Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 94. Cigna Recent Development
Table 95. Diagnostic Laboratory of Oklahoma Company Details
Table 96. Diagnostic Laboratory of Oklahoma Business Overview
Table 97. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product
Table 98. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 99. Diagnostic Laboratory of Oklahoma Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 103. GlaxoSmithKline Recent Development
Table 104. HealthLink BC Company Details
Table 105. HealthLink BC Business Overview
Table 106. HealthLink BC Rubella Diagnostic Testing Product
Table 107. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 108. HealthLink BC Recent Development
Table 109. Mayo Clinic Company Details
Table 110. Mayo Clinic Business Overview
Table 111. Mayo Clinic Rubella Diagnostic Testing Product
Table 112. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 113. Mayo Clinic Recent Development
Table 114. Ortho Clinical Diagnostics Company Details
Table 115. Ortho Clinical Diagnostics Business Overview
Table 116. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product
Table 117. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 118. Ortho Clinical Diagnostics Recent Development
Table 119. True Health Company Details
Table 120. True Health Business Overview
Table 121. True Health Rubella Diagnostic Testing Product
Table 122. True Health Revenue in Rubella Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 123. True Health Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rubella Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. Flow Cytometry Features
Figure 3. Latex Slide Agglutination Test Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Immunoassays Features
Figure 6. Serological Testing Features
Figure 7. Clinical Evaluation Features
Figure 8. Global Rubella Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Commercial Case Studies
Figure 11. Physician Offices Case Studies
Figure 12. Public Health Labs Case Studies
Figure 13. Other Case Studies
Figure 14. Rubella Diagnostic Testing Report Years Considered
Figure 15. Global Rubella Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Rubella Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Rubella Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Rubella Diagnostic Testing Market Share by Regions (2022-2027)
Figure 19. Global Rubella Diagnostic Testing Market Share by Players in 2020
Figure 20. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rubella Diagnostic Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2020
Figure 22. Global Rubella Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 23. Global Rubella Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 24. North America Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Rubella Diagnostic Testing Market Share by Type (2016-2027)
Figure 26. North America Rubella Diagnostic Testing Market Share by Application (2016-2027)
Figure 27. North America Rubella Diagnostic Testing Market Share by Country (2016-2027)
Figure 28. United States Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Rubella Diagnostic Testing Market Share by Type (2016-2027)
Figure 32. Europe Rubella Diagnostic Testing Market Share by Application (2016-2027)
Figure 33. Europe Rubella Diagnostic Testing Market Share by Country (2016-2027)
Figure 34. Germany Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Rubella Diagnostic Testing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Rubella Diagnostic Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Rubella Diagnostic Testing Market Share by Region (2016-2027)
Figure 44. China Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Rubella Diagnostic Testing Market Share by Type (2016-2027)
Figure 52. Latin America Rubella Diagnostic Testing Market Share by Application (2016-2027)
Figure 53. Latin America Rubella Diagnostic Testing Market Share by Country (2016-2027)
Figure 54. Mexico Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Rubella Diagnostic Testing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Rubella Diagnostic Testing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Rubella Diagnostic Testing Market Share by Country (2016-2027)
Figure 60. Turkey Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Rubella Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 64. Beckman Coulter Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 65. Bio Rad Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 66. Biogate Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 67. BioMerieux SA Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 68. Cigna Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 69. Diagnostic Laboratory of Oklahoma Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 71. HealthLink BC Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 72. Mayo Clinic Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 73. Ortho Clinical Diagnostics Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 74. True Health Revenue Growth Rate in Rubella Diagnostic Testing Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の診察室診断検査市場規模・現状・予測（2021年-2027年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…- 世界の診察室診断検査市場規模・現状・予測（2021年-2027年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…
- 世界の大腸菌（E. Coli）診断検査市場規模・現状・予測（2021年-2027年） Escherichia coli (E. coli), is a bacterium which normally lives in the intestines of humans and animals. Major sign and symptoms of E. coli infection include abdominal pain, diarrhea, and nausea and vomiting. Cases of E. coli infection are usually confirmed by the detection of bacteria in stool samp…
- 世界の豚診断検査市場規模・現状・予測（2021年-2027年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …
- 世界の髄膜炎診断検査市場規模・現状・予測（2021年-2027年） Inflammation to the meninges is known as meningitis. Most common cause of meningitis is bacteria or virus. Other causes include certain illness, medications or suffering from some other disease such as tuberculosis, or HIV (Human Immunodeficiency Virus). The testing for meningitis can be done using …